News & Analysis

A pivotal life sciences investment for London’s Canary Wharf

Canary Wharf Group and AXA IM Alts' Kadans Science Partner will be investing £500m in Europe's largest commercial lab building.

ByJessica Nangle

13 May 2022•2 mins read

Managers Europe

Related articles

alt

Alpaca Real Estate closes debut fund on $223m

5 August 2026 · 3 mins read

alt

TPG expects multiple first closes in real estate by year end

5 August 2026 · 3 mins read

alt

NJDOI’s Khan: Real estate pacing continues despite executive departures

4 August 2026 · 3 mins read

alt

Blue Owl closes record-setting debut European net lease fund

4 August 2026 · 4 mins read

alt

TPG’s China real estate boss to depart after two decades

4 August 2026 · 2 mins read

alt

Doug Doughty joins Davis Companies to lead fundraising

3 August 2026 · 2 mins read

alt

CenterSquare’s Robert Holuba: Asian investors are drawn to the US

31 July 2026 · 3 mins read

motif